Joshua Tseng
Overview
Explore the profile of Joshua Tseng including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
31
Citations
135
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Tseng J, DiPeri T, Gonsalves N, Chen Y, Ben-Shlomo A, Shouhed D, et al.
Surg Endosc
. 2022 Mar;
36(12):9288-9296.
PMID: 35246741
Background: Surgical resection with negative margins is the treatment of choice for adrenocortical carcinoma (ACC). This study was undertaken to determine factors associated with negative resection margins. Methods: National Cancer...
12.
Natalie R, Tseng J, Loh J, Yi-Ren Chan I, Tan H, Jarjue E, et al.
ASSETS
. 2022 Feb;
17.
PMID: 35187542
The majority of online video contents remain inaccessible to people with visual impairments due to the lack of audio descriptions to depict the video scenes. Content creators have traditionally relied...
13.
Tseng J, Korman J, Noureddin M, Shouhed D, Miller J, Feng X, et al.
Obes Surg
. 2021 Nov;
32(2):463-471.
PMID: 34816355
Background: Nonalcoholic steatohepatitis (NASH) is common in patients with obesity. Liver biopsy (LB) can be routinely or selectively performed during bariatric surgery to identify patients with NASH. Methods: Patients undergoing...
14.
Tseng J, DiPeri T, Chen Y, Shouhed D, Ben-Shlomo A, Burch M, et al.
Ann Surg Oncol
. 2021 Nov;
29(3):1965-1970.
PMID: 34792698
Background: Adrenocortical carcinoma (ACC) staging does not account for the number of positive nodes. The prognostic value of quantitative metastatic nodal burden is unknown. Methods: The National Cancer Database was...
15.
Mohan S, Tseng J, Angarita S, Marumoto A, Dadmanesh F, Amersi F, et al.
Am Surg
. 2021 Oct;
87(10):1533-1538.
PMID: 34689588
Phyllodes tumors (PT) are rare fibroepithelial neoplasms that are classified as benign, borderline, or malignant. Patients with PT diagnosed between 2009 and 2019 were identified from a prospectively maintained single...
16.
Mohan S, Tseng J, Srour M, Chung A, Marumoto A, Angarita S, et al.
Am Surg
. 2021 Oct;
87(10):1539-1544.
PMID: 34672825
Background: Cancer Program Practice Profile Reports (CP3R) metrics were released by the Commission on Cancer to provide standards for high-quality care. One metric is the recommendation of combination chemotherapy or...
17.
Mohan S, Tseng J, Marumoto A, Angarita S, Dadmanesh F, Amersi F, et al.
Ann Surg Oncol
. 2021 Oct;
29(4):2193-2199.
PMID: 34671884
Introduction: Fibroepithelial lesions of the breast (FEL) are heterogeneous lesions ranging from fibroadenomas (FA) to phyllodes tumors (PT). FEL with cellular stroma are diagnostic challenges on core needle biopsy (CNB)...
18.
Tseng J, Miller J, Johnson J, Waters K, Gangi A, Gong J, et al.
J Gastrointest Oncol
. 2021 Sep;
12(4):1308-1325.
PMID: 34532090
Background: The burden of gastric cancer involving Hispanic patients in the United States is growing as both the population and the incidence of gastric cancer in this group increases. This...
19.
Tseng J, DiPeri T, Chen Y, Ben-Shlomo A, Shouhed D, Phillips E, et al.
J Surg Res
. 2021 Jul;
267:651-659.
PMID: 34273795
Introduction: Surgery is the initial treatment of choice for patients with resectable adrenocortical carcinoma (ACC). We sought to determine factors associated with non-operative management of resectable ACC. Methods: 2004-2016 National...
20.
Srour M, Tseng J, Chung A, Giuliano A, Amersi F
Ann Surg Oncol
. 2021 Jun;
28(13):8589-8599.
PMID: 34136983
Introduction: The Commission on Cancer (CoC) issues Cancer Program Practice Profile Reports (CP3R) that set standards for high-quality care. Three metrics for breast cancer include radiation within 1 year for...